by Mybiogate | Nov 20, 2020 | Industry Research
Author: HE Sheng Migraine is a common neurological disease, which can be chronic. According to the Migraine Research Foundation, symptoms include a severe throbbing recurring pain, usually on one side of the head and at least one of the following: “visual... by Mybiogate | Nov 17, 2020 | Chinese company profile
Qilu Pharmaceutical 2019 Revenue: US$ 3.3 billion Number of Employees: 2,3000+ Founded: 1992 Overview Qilu Pharmaceutical is one of the leading vertically integrated pharmaceutical companies in China, focusing on the development, manufacturing, and marketing of... by Mybiogate | Nov 17, 2020 | Industry Research
Author: Ginger Ding Following PD-(L)1, high-end players have quickly joined the race to develop the new star T cell immunoreceptors with immunoglobulin and ITIM domain (TIGIT). Roche, BMS, Merck and other international pharmaceutical companies have all entered.... by Mybiogate | Nov 13, 2020 | Industry Research
Author: MJ Yuan Part 2 of a series on the Analgesic Drug Market. Part 1 focused on China while Part 2 takes a global perspective. Opioid Abuse is a Serious Problem, A New Trend in Non-Opioid Medication Begins In 1996, Purdue Pharmaceuticals, run by the Sackler... by Mybiogate | Nov 12, 2020 | Chinese company profile
Luye Pharma Group 2019 Revenue: US$ 0.96 Billion Number of Employees: 4,716 Founded: 1994 Overview Luye Pharma Group, a member of Luye Life Sciences Group, is an international pharmaceutical company focusing on drugs targeting the central nervous system (CNS),...